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Th e peri-operative use of ﬂ uid and inotropes guided by 
cardiac output monitoring is variously known as optimi-
zation, ﬂ ow-guided therapy, and goal-directed therapy 
(GDT). In this issue of Critical Care, Cecconi and 
colleagues [1], who are experienced researchers in this 
ﬁ eld, report the ﬁ ndings of an interesting single-center 
trial of GDT in patients undergoing hip replacement 
under regional anaesthesia. Th e ﬁ ndings of this investi-
gation suggest that GDT may be associated with reduced 
adverse event rates after orthopedic surgery. Th ere is a 
clear need to improve survival for patients undergoing 
major surgery [2,3], and in many small trials, GDT has 
been associated with better clinical outcomes, particu-
larly following high-risk procedures [4-6]. Th is beneﬁ cial 
eﬀ ect appears to be related to improvements in 
micro vascular ﬂ ow and tissue oxygenation [7]. Th e 
ﬁ ndings of previous studies have suggested beneﬁ t in 
patients undergoing proximal femoral fracture repair 
[8,9], but we are unaware of any previous trials of GDT in 
elective orthopedic surgery. Consequently, there has 
been little evidence to inform the use of GDT in this large 
popu lation of patients. Th ere are distinct challenges 
associated with the design and conduct of GDT trials, 
and these challenges are not easily solved. Th us, the 
ﬁ ndings of this and all previous GDT trials must be 
interpreted in the context of the design choices that the 
investigators have made.
GDT is a term that describes a potentially more eﬀ ec-
tive and objective method to determine the optimal dose 
of intravenous ﬂ uid and inotropic therapy through the 
use of a clinical algorithm. Ordinarily, the clinician will 
administer ﬂ uid or inotropic therapy (or both) on a 
subjective basis according to their preferred clinical end-
points. Hence, there is signiﬁ cant variability in clinical 
practice which, in a small trial, must be replaced by a 
control group algorithm designed to reﬂ ect best usual 
care. Failure to use this approach will expose the 
investigators to the possible accusation of manipulating 
the trial outcome through poor control group care. In the 
recent past, even the suggestion of such impropriety has 
proven damaging for highly respected investigators [10]. 
In the trial of Cecconi and colleagues [1], the choice of 
arterial pressure as a control group end-point for ﬂ uid 
therapy illustrates the dilemma. Fluid challenges are 
commonly administered to correct hypo tension. However, 
under regional anaesthesia, arterial hypotension is more 
likely to result from vasodilatation than hypovolemia. We 
could therefore argue that usual practice is incorrect in 
this case and yet more eﬀ ective control group care will 
diminish any apparent treatment eﬀ ect of GDT. It is easy 
to criticize control group care in clinical trials of complex 
interventions though much harder to ﬁ nd a better 
alternative. In large multicenter trials, the variable nature 
of usual care is much less likely to lead to an erroneous 
ﬁ nding. Even then, it would be advisable to recommend 
some treatment standards to avoid practice misalign-
ment. Less critically, the GDT algorithm must result in 
Abstract
In this issue of Critical Care, Cecconi and colleagues 
report the fi ndings of a small trial of goal-directed 
hemodynamic therapy (GDT) in patients undergoing 
major orthopedic surgery under regional anesthesia. 
This is an interesting trial and the fi rst of which we are 
aware to test the effi  cacy of GDT in this patient group. 
The fi ndings suggest that this intervention is associated 
with improved adverse event rates after surgery. 
However, in this trial, as in all small trials of GDT, the 
potential for bias leaves some uncertainty regarding 
how widely the fi ndings should be implemented. 
Such limitations may be impossible to completely 
eliminate from trials of complex interventions, but 
large multicenter trials may allow us to substantially 
decrease bias and improve the generalizability of the 
fi ndings.
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adequate intervention in the majority of patients while 
minimizing potential harm. In the trial of Cecconi and 
colleagues, only 65% of patients achieved the pre deter-
mined target for oxygen delivery (DO2). Th is observation 
likely reﬂ ects a GDT algorithm that incorporates 
judicious limits to the dose of inotropic therapy. It seems 
clear that the continued pursuit of hemodynamic goals in 
patients who do not respond is harmful [11]. Th e adverse 
eﬀ ects of ﬂ uid and inotropic therapy will be most serious 
for patients with signiﬁ cant heart disease. In this respect, 
it would have been helpful to report the timing of 
cardiovascular complications. Arrhythmias may be trig-
gered by hypovolemia or myocardial ischemia, but the 
eﬀ ect of study group allocation would have a more 
transient eﬀ ect on this category of complications than for 
others such as infection.
Blinding is another important potential source of bias 
in GDT trials. GDT is a complex intervention that 
involves human decision making. In this context, it is 
impossible to fully blind investigators to study group 
allocation. Small GDT trials are particularly vulnerable to 
bias, and investigators may ﬁ nd it diﬃ  cult to demonstrate 
the adequacy of their procedures for assessing non-
binary outcomes such as complications. Th is problem 
can be minimized through the use of blinded assessors 
who determine clinical outcomes according to predeter-
mined criteria. In the report by Cecconi and colleagues, 
these processes could be better described to clearly 
demonstrate methodological rigor. Th e use of scoring 
systems such as the postoperative morbidity survey 
(POMS) may prove useful for assessment of minor 
morbidity, but once again, large multicenter trials would 
appear to be the most eﬀ ective way to reduce bias.
Th is interesting trial adds another piece to the jigsaw of 
optimal peri-operative hemodynamic therapy. Th e appa-
rent eﬃ  cacy of this approach during elective orthopedic 
surgery in self-ventilating patients under regional anes-
thesia is of particular interest. We agree with the authors 
that GDT has a potential role in the treatment of such 
patients. We also agree that further research is required 
to conﬁ rm their ﬁ ndings. Small clinical trials add to the 
literature, but the lack of conﬁ rmation in large trials is a 
signiﬁ cant limitation of the evidence base for GDT. We 
hope that this interesting investigation will be followed 
by a robustly designed multicenter trial designed to 
conﬁ rm or refute the ﬁ ndings.
Abbreviation
GDT, goal-directed therapy.
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